In situ blood vessel regeneration using neuropeptide substance P-conjugated small-diameter vascular grafts

Muhammad Shafiq, Lina Wang, Dengke Zhi, Qiuying Zhang, Kai Wang, Lianyong Wang, Dong Hwee Kim, Deling Kong, Soo Hyun Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In situ blood vessel regeneration through host stem/progenitor cell mobilization may hold great promise for vascular reconstruction. Neuropeptide substance P (SP) has been shown to accelerate tissue repair by endogenous cell mobilization and recruitment. This study was aimed to evaluate the vascular regeneration potential of SP and heparin co-tethered vascular grafts. Polycaprolactone (PCL), PCL/SP-conjugated poly(L-lactide-co-ε-caprolactone) (PLCL-SP) (SP), and PCL/PLCL-SP/heparin-conjugated PLCL (Hep/SP) vascular grafts were implanted as rat abdominal aorta substitutes for up to 2 weeks and 4 weeks. Ex vivo results delineate that heparin can improve the hemocompatibility and SP can recruit mesenchymal stem cells. Histological and immunohistochemical staining reveal higher cellular infiltration and homogeneous cell distribution in SP and Hep/SP grafts than that of the control grafts. At 4 weeks, SP and Hep/SP grafts show the presence of cobblestone-like cells on the luminal side, whereas the surface of PCL grafts remains bare. Immunoflourescence staining using von Willibrand factor (vWF) antibody shows improved endothelialization in SP and Hep/SP grafts compared with the PCL grafts. SP and Hep/SP grafts also exhibit more numbers of α-smooth muscle actin-positive cells and laminin+ blood vessels than that of the control group. Evaluation of inflammatory response reveals that three groups did not differ in terms of the numbers of CD68+ macrophages, whereas SP and Hep/SP grafts show higher numbers of CD206+ macrophages. These results indicate that SP can induce endogenous tissue regeneration in cell-free grafts, which may be of great interest for regenerative medicine and tissue engineering applications.

Original languageEnglish
JournalJournal of Biomedical Materials Research - Part B Applied Biomaterials
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Blood vessels
Substance P
Neuropeptides
Grafts
Polycaprolactone
Macrophages
Stem cells
Heparin
Tissue regeneration
Tissue engineering
Infiltration
Antibodies
Muscle
Rats
Repair
Cells
Tissue
Laminin

Keywords

  • bioactive material
  • graft/copolymer
  • stem cells
  • tissue engineering
  • vascular graft

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering

Cite this

In situ blood vessel regeneration using neuropeptide substance P-conjugated small-diameter vascular grafts. / Shafiq, Muhammad; Wang, Lina; Zhi, Dengke; Zhang, Qiuying; Wang, Kai; Wang, Lianyong; Kim, Dong Hwee; Kong, Deling; Kim, Soo Hyun.

In: Journal of Biomedical Materials Research - Part B Applied Biomaterials, 01.01.2018.

Research output: Contribution to journalArticle

Shafiq, Muhammad ; Wang, Lina ; Zhi, Dengke ; Zhang, Qiuying ; Wang, Kai ; Wang, Lianyong ; Kim, Dong Hwee ; Kong, Deling ; Kim, Soo Hyun. / In situ blood vessel regeneration using neuropeptide substance P-conjugated small-diameter vascular grafts. In: Journal of Biomedical Materials Research - Part B Applied Biomaterials. 2018.
@article{2da7057dd3424ffbb03be991f296b1fe,
title = "In situ blood vessel regeneration using neuropeptide substance P-conjugated small-diameter vascular grafts",
abstract = "In situ blood vessel regeneration through host stem/progenitor cell mobilization may hold great promise for vascular reconstruction. Neuropeptide substance P (SP) has been shown to accelerate tissue repair by endogenous cell mobilization and recruitment. This study was aimed to evaluate the vascular regeneration potential of SP and heparin co-tethered vascular grafts. Polycaprolactone (PCL), PCL/SP-conjugated poly(L-lactide-co-ε-caprolactone) (PLCL-SP) (SP), and PCL/PLCL-SP/heparin-conjugated PLCL (Hep/SP) vascular grafts were implanted as rat abdominal aorta substitutes for up to 2 weeks and 4 weeks. Ex vivo results delineate that heparin can improve the hemocompatibility and SP can recruit mesenchymal stem cells. Histological and immunohistochemical staining reveal higher cellular infiltration and homogeneous cell distribution in SP and Hep/SP grafts than that of the control grafts. At 4 weeks, SP and Hep/SP grafts show the presence of cobblestone-like cells on the luminal side, whereas the surface of PCL grafts remains bare. Immunoflourescence staining using von Willibrand factor (vWF) antibody shows improved endothelialization in SP and Hep/SP grafts compared with the PCL grafts. SP and Hep/SP grafts also exhibit more numbers of α-smooth muscle actin-positive cells and laminin+ blood vessels than that of the control group. Evaluation of inflammatory response reveals that three groups did not differ in terms of the numbers of CD68+ macrophages, whereas SP and Hep/SP grafts show higher numbers of CD206+ macrophages. These results indicate that SP can induce endogenous tissue regeneration in cell-free grafts, which may be of great interest for regenerative medicine and tissue engineering applications.",
keywords = "bioactive material, graft/copolymer, stem cells, tissue engineering, vascular graft",
author = "Muhammad Shafiq and Lina Wang and Dengke Zhi and Qiuying Zhang and Kai Wang and Lianyong Wang and Kim, {Dong Hwee} and Deling Kong and Kim, {Soo Hyun}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/jbm.b.34260",
language = "English",
journal = "Journal of Biomedical Materials Research - Part B Applied Biomaterials",
issn = "1552-4973",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - In situ blood vessel regeneration using neuropeptide substance P-conjugated small-diameter vascular grafts

AU - Shafiq, Muhammad

AU - Wang, Lina

AU - Zhi, Dengke

AU - Zhang, Qiuying

AU - Wang, Kai

AU - Wang, Lianyong

AU - Kim, Dong Hwee

AU - Kong, Deling

AU - Kim, Soo Hyun

PY - 2018/1/1

Y1 - 2018/1/1

N2 - In situ blood vessel regeneration through host stem/progenitor cell mobilization may hold great promise for vascular reconstruction. Neuropeptide substance P (SP) has been shown to accelerate tissue repair by endogenous cell mobilization and recruitment. This study was aimed to evaluate the vascular regeneration potential of SP and heparin co-tethered vascular grafts. Polycaprolactone (PCL), PCL/SP-conjugated poly(L-lactide-co-ε-caprolactone) (PLCL-SP) (SP), and PCL/PLCL-SP/heparin-conjugated PLCL (Hep/SP) vascular grafts were implanted as rat abdominal aorta substitutes for up to 2 weeks and 4 weeks. Ex vivo results delineate that heparin can improve the hemocompatibility and SP can recruit mesenchymal stem cells. Histological and immunohistochemical staining reveal higher cellular infiltration and homogeneous cell distribution in SP and Hep/SP grafts than that of the control grafts. At 4 weeks, SP and Hep/SP grafts show the presence of cobblestone-like cells on the luminal side, whereas the surface of PCL grafts remains bare. Immunoflourescence staining using von Willibrand factor (vWF) antibody shows improved endothelialization in SP and Hep/SP grafts compared with the PCL grafts. SP and Hep/SP grafts also exhibit more numbers of α-smooth muscle actin-positive cells and laminin+ blood vessels than that of the control group. Evaluation of inflammatory response reveals that three groups did not differ in terms of the numbers of CD68+ macrophages, whereas SP and Hep/SP grafts show higher numbers of CD206+ macrophages. These results indicate that SP can induce endogenous tissue regeneration in cell-free grafts, which may be of great interest for regenerative medicine and tissue engineering applications.

AB - In situ blood vessel regeneration through host stem/progenitor cell mobilization may hold great promise for vascular reconstruction. Neuropeptide substance P (SP) has been shown to accelerate tissue repair by endogenous cell mobilization and recruitment. This study was aimed to evaluate the vascular regeneration potential of SP and heparin co-tethered vascular grafts. Polycaprolactone (PCL), PCL/SP-conjugated poly(L-lactide-co-ε-caprolactone) (PLCL-SP) (SP), and PCL/PLCL-SP/heparin-conjugated PLCL (Hep/SP) vascular grafts were implanted as rat abdominal aorta substitutes for up to 2 weeks and 4 weeks. Ex vivo results delineate that heparin can improve the hemocompatibility and SP can recruit mesenchymal stem cells. Histological and immunohistochemical staining reveal higher cellular infiltration and homogeneous cell distribution in SP and Hep/SP grafts than that of the control grafts. At 4 weeks, SP and Hep/SP grafts show the presence of cobblestone-like cells on the luminal side, whereas the surface of PCL grafts remains bare. Immunoflourescence staining using von Willibrand factor (vWF) antibody shows improved endothelialization in SP and Hep/SP grafts compared with the PCL grafts. SP and Hep/SP grafts also exhibit more numbers of α-smooth muscle actin-positive cells and laminin+ blood vessels than that of the control group. Evaluation of inflammatory response reveals that three groups did not differ in terms of the numbers of CD68+ macrophages, whereas SP and Hep/SP grafts show higher numbers of CD206+ macrophages. These results indicate that SP can induce endogenous tissue regeneration in cell-free grafts, which may be of great interest for regenerative medicine and tissue engineering applications.

KW - bioactive material

KW - graft/copolymer

KW - stem cells

KW - tissue engineering

KW - vascular graft

UR - http://www.scopus.com/inward/record.url?scp=85054792400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054792400&partnerID=8YFLogxK

U2 - 10.1002/jbm.b.34260

DO - 10.1002/jbm.b.34260

M3 - Article

AN - SCOPUS:85054792400

JO - Journal of Biomedical Materials Research - Part B Applied Biomaterials

JF - Journal of Biomedical Materials Research - Part B Applied Biomaterials

SN - 1552-4973

ER -